Thus, it is plausible that PKCζ signaling might be important for constitutive NFκB activity responsible for breast cancer progression and this observation is further supported by our observation that both PKCζ and functionally active phospho-PKCζ expression is significantly higher in aggressive forms of breast cancer. Here, NFKB1 is linked to breast cancer.